AC Immune S.A. (ACIU) vs Invivyd, Inc. (IVVD)
A side-by-side comparison of AC Immune S.A. and Invivyd, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ACIU
AC Immune S.A.
$2.56HealthcareDelayed quote: Oct 6, 2026, 12:58 PM EDT
IVVD
Invivyd, Inc.
$0.82HealthcareDelayed quote: Oct 6, 2026, 1:00 PM EDT
Total return — ACIU vs IVVD
growth of $100 · dividends reinvested · last 5yACIU -62.0% (-17.6%/yr)IVVD -96.0% (-47.4%/yr)ACIU compounded faster over this window
Log scale — wide-divergence pair
ACIU IVVD
ACIU vs IVVD: by the numbers
- •ACIU is the larger company ($260M vs $241M market cap).
- •Both run net losses; IVVD's is the smaller (-183.90% vs -249.94% net margin).
Metrics side by side
Valuation
| Metric | ACIU | IVVD |
|---|---|---|
| P/S ratio | 11.99 | 4.12 |
| P/B ratio | 5.98 | 1.33 |
Profitability
| Metric | ACIU | IVVD |
|---|---|---|
| Gross margin | 100.00% | 91.35% |
| Operating margin | -1927.32% | -103.99% |
| Net margin | -249.94% | -183.90% |
| ROE | -124.67% | -59.27% |
| ROIC | -89.43% | -59.90% |
Growth (annualized)
| Metric | ACIU | IVVD |
|---|---|---|
| Revenue CAGR (5Y) | -23.70% | N/A |
| Total return CAGR (5Y) | -16.03% | -51.69% |
Frequently asked
- How have ACIU and IVVD total returns compared?
- Over the past 5 years, ACIU delivered -16.03% and IVVD delivered -51.69% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.